Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Open-label Randomized Controlled Prospective Phase II Study Evaluating the Efficacy of Selective Internal Radiation Therapy (Yttrium-90 Glass Microspheres) Combined With Capecitabine in the Neoadjuvant Setting of Operable Intrahepatic CHOlangiocarcinoma

NCT05265208 is registered in ClinicalTrials.gov with Center Eugene Marquis as lead sponsor.

NCT NCT05265208
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05265208 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Open-label Randomized Controlled Prospective Phase II Study Evaluating the Efficacy of Selective Internal Radiation Therapy (Yttrium-90 Glass Microspheres) Combined With Capecitabine in the Neoadjuvant Setting of Operable Intrahepatic CHOlangiocarcinoma
Lead sponsor
Center Eugene Marquis
Phase
Phase 2
Overall status
Recruiting
Start date
February 4, 2022
Completion date
February 4, 2030
Enrollment
62 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

resectable intrahepatic cholangiocarcinoma